My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 135

    1.

    Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

    Markowitz N, Quinn EL, Saravolatz LD.

    Ann Intern Med. 1992 Sep 1;117(5):390-8.PMID: 1503330 [PubMed - indexed for MEDLINE]Related articles

    2.

    A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.

    Fox BC, Sollinger HW, Belzer FO, Maki DG.

    Am J Med. 1990 Sep;89(3):255-74.PMID: 2118307 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.

    Markowitz N, Saravolatz LD.

    Rev Infect Dis. 1987 Mar-Apr;9 Suppl 2:S218-29.PMID: 3495027 [PubMed - indexed for MEDLINE]Related articles

    4.

    A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.

    Maki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO.

    J Lab Clin Med. 1992 Jan;119(1):11-24.PMID: 1727903 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.

    de Górgolas M, Avilés P, Verdejo C, Fernández Guerrero ML.

    Antimicrob Agents Chemother. 1995 Apr;39(4):953-7.PMID: 7786002 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

    Small PM, Chambers HF.

    Antimicrob Agents Chemother. 1990 Jun;34(6):1227-31.PMID: 2393284 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.

    Grim SA, Rapp RP, Martin CA, Evans ME.

    Pharmacotherapy. 2005 Feb;25(2):253-64. Review.PMID: 15767239 [PubMed - indexed for MEDLINE]Related articles

    8.

    Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.

    Adra M, Lawrence KR.

    Ann Pharmacother. 2004 Feb;38(2):338-41. Epub 2003 Dec 30. Review.PMID: 14742775 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.

    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H; 307 Study Group.

    J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i17-28.PMID: 18684703 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility.

    Capitano B, Leshem OA, Nightingale CH, Nicolau DP.

    J Am Geriatr Soc. 2003 Jan;51(1):10-6.PMID: 12534839 [PubMed - indexed for MEDLINE]Related articles

    11.

    Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.

    Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA, Corey GR, Abrutyn E.

    J Antimicrob Chemother. 2008 Dec;62(6):1413-21. Epub 2008 Sep 8.PMID: 18782781 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.

    Walsh TJ, Standiford HC, Reboli AC, John JF, Mulligan ME, Ribner BS, Montgomerie JZ, Goetz MB, Mayhall CG, Rimland D, et al.

    Antimicrob Agents Chemother. 1993 Jun;37(6):1334-42.PMID: 8328783 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.

    Roghmann MC.

    Arch Intern Med. 2000 Apr 10;160(7):1001-4.PMID: 10761966 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

    Hughes WT, Dankner WM, Yogev R, Huang S, Paul ME, Flores MA, Kline MW, Wei LJ; Pediatric AIDS Clinical Trials Group 254 Team.

    Clin Infect Dis. 2005 Jan 1;40(1):136-45. Epub 2004 Dec 6.PMID: 15614703 [PubMed - indexed for MEDLINE]Related articles

    15.

    High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.

    Arch Intern Med. 2006 Oct 23;166(19):2138-44.PMID: 17060545 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Vancomycin therapy for methicillin-resistant Staphylococcus aureus.

    Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R.

    Ann Intern Med. 1982 Sep;97(3):344-50.PMID: 7114631 [PubMed - indexed for MEDLINE]Related articles

    17.

    Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.

    [No authors listed]

    J Infect Dis. 1984 Sep;150(3):372-9.PMID: 6384377 [PubMed - indexed for MEDLINE]Related articles

    18.

    A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.

    Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP; Swiss Staphylococcal Study Group.

    Clin Infect Dis. 2004 Nov 1;39(9):1285-92. Epub 2004 Oct 11.PMID: 15494904 [PubMed - indexed for MEDLINE]Related articles

    19.

    [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin]

    Bismuth R, Jarlier V, Grosset J.

    Pathol Biol (Paris). 1983 May;31(5):429-33. French. PMID: 6353335 [PubMed - indexed for MEDLINE]Related articles

    20.

    Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.

    N Engl J Med. 1999 Feb 18;340(7):493-501.PMID: 10021469 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity